Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HTT | P42858 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10579384 | 0.80 | NPC1 (0.42) | POLBSMN1; SMN2LMNANPC1MAPT | |
| SCHEMBL31027122 | 0.78 | NPC1 (0.50) | POLBALDH1A1LMNANPC1MAPT | |
| SCHEMBL11884923 | 0.71 | PEPD (0.43) | ALDH1A1LMNANPC1MAPTGAA | |
| SCHEMBL8386697 | 0.70 | TDP1 (0.44) | POLBALDH1A1HTTLMNAMAPT | |
| SCHEMBL10763332 | 0.68 | GSK3B (0.41) | ALDH1A1NPC1RAB9AGAAKDM4E | |
| SCHEMBL14435888 | 0.68 | HTT (0.49) | POLBALDH1A1HTTSMN1; SMN2NPC1 | |
| SCHEMBL30710827 | 0.67 | CYP1A2 (0.40) | ALDH1A1LMNANPSR1MAPTS1PR4 | |
| SCHEMBL11249037 | 0.65 | POLB (0.38) | POLBALDH1A1HTTSMN1; SMN2LMNA | |
| SCHEMBL13787110 | 0.64 | MGLL (0.45) | ALDH1A1HTTLMNACA9KMT2A | |
| SCHEMBL11337998 | 0.64 | MGLL (0.45) | ALDH1A1HTTLMNACA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118231766-A | Application of oxadiazolone compound, electrolyte and preparation method thereof, solid electrolyte membrane, lithium ion battery and electric equipment | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| EP-0854871-B1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 2000-08-16 | — | — | EP | claimed |
| US-6013804-A | FOR CONTROLLING ANIMAL PESTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-11 | — | — | US | claimed |
| EP-0854871-A1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 1998-07-29 | — | — | EP | claimed |
| WO-1997008158-A1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | claimed |
| EP-4562016-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-118231766-A | Application of oxadiazolone compound, electrolyte and preparation method thereof, solid electrolyte membrane, lithium ion battery and electric equipment | 比亚迪股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| WO-2024026483-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-2238131-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - Portela & Ca., S.A. (PT) | 2010-10-13 | — | — | EP | disclosed |
| EP-2238131-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - Portela & Ca., S.A. (PT) | 2010-10-13 | — | — | EP | disclosed |
| EP-2238131-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - Portela & Ca., S.A. (PT) | 2010-10-13 | — | — | EP | disclosed |
| WO-2010074587-A2 | 5-O-SUBSTITUTED 3-N-ARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - PORTELA & CA., S.A. (PT) | 2010-07-01 | — | — | WO | disclosed |
| WO-2009084970-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL-PORTELA & COMPANHIA, S.A. (PT) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009084970-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL-PORTELA & COMPANHIA, S.A. (PT) | 2009-07-09 | — | — | WO | disclosed |
| EP-0854871-B1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 2000-08-16 | — | — | EP | disclosed |
| US-6013804-A | FOR CONTROLLING ANIMAL PESTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-11 | — | — | US | disclosed |
| US-5869509-A | TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-02-09 | — | — | US | disclosed |
| EP-0854871-A1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AG (DE) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997008158-A1 | 1,3,4-OXADIAZOLIN-2-ONES AND THEIR USE AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |